跳至主要内容
临床试验/NCT03459105
NCT03459105已完成不适用

Ultrasound-assisted Versus Conventional Landmark-guided Spinal Anesthesia in Patients With Abnormal Spinal Anatomy

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2018年3月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
1
主要终点
the number of needle passes

研究概览

简要总结

Spinal anesthesia can be challenging in patients with lumbar scoliosis or previous lumbar spine surgery. This study aims to evaluate whether the use of the ultrasound-assisted spinal anesthesia reduces the number of passes required to successful dural puncture compared with the conventional surface landmark-guided technique in patients with abnormal spinal anatomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients scheduled to undergoing elective orthopedic surgery under spinal anesthesia,
  • with ASA physical status classification I, II, III,
  • and with (1) or (2)
  • documented scoliosis in preoperative L-S-Spine X-ray (Cobb abgle > 10 degree)
  • previous history of lumbar spinal surgery

排除标准

  • Patients with contraindication to spinal anesthesia (coagulopathy, local infection, allergy to local anesthetic)
  • Patients with morbid cardiac diseases
  • Pregnancy

研究组 & 干预措施

Ultrasound-assisted

Experimental

Preprocedural ultrasound-assisted paramedian spinal anesthesia will be performed. 0.5% heavy bupivacaine will be injected to intrathecal space for spinal anesthesia.

干预措施: Ultrasound-assisted paramedian spinal anesthesia (Procedure)

Ultrasound-assisted

Experimental

Preprocedural ultrasound-assisted paramedian spinal anesthesia will be performed. 0.5% heavy bupivacaine will be injected to intrathecal space for spinal anesthesia.

干预措施: 0.5% heavy bupivacaine (Drug)

Landmark-guided

Active Comparator

Landmark-guided spinal anesthesia will be performed, via either midline or paramedian approach. 0.5% heavy bupivacaine will be injected to intrathecal space for spinal anesthesia.

干预措施: Landmark-guided spinal anesthesia (Procedure)

Landmark-guided

Active Comparator

Landmark-guided spinal anesthesia will be performed, via either midline or paramedian approach. 0.5% heavy bupivacaine will be injected to intrathecal space for spinal anesthesia.

干预措施: 0.5% heavy bupivacaine (Drug)

结局指标

主要结局

the number of needle passes

时间窗: Intraoperative (from the first insertion of needle to patient's skin, until the completion of spinal anesthetic injection)

the number of forward advancements of the spinal needle in a given interspinous space, i.e., withdrawal and redirection of spinal needle without exiting the skin

次要结局

  • Periprocedural pain(Patients will be asked immediately after the completion of spinal anesthesia)
  • Time taken for performing spinal anesthetic(Intraoperative (from insertion of the needle to the completion of injection))
  • dermatome level of sensory block(5, 10, 15 minutes after the completion of spinal anesthetic injection)
  • Periprocedural discomfort score(Patients will be asked immediately after the completion of spinal anesthesia)
  • Number of spinal needle insertion attempts(Intraoperative (from the first insertion of needle to patient's skin, until the completion of spinal anesthetic injection))
  • Time for identifying landmarks(1 day (time taken for establish the landmark, from start of palpation/US scanning to completion of palpation/scanning))
  • Incidence of radicular pain, paraesthesia, and blood tapping in the spinal needle(Intraoperative (from the first insertion of needle, until the completion of spinal anesthetic injection))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jin-Tae Kim

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验